Cargando…
rtM204Q May Serve as a Novel Lamivudine-Resistance-Associated Mutation of Hepatitis B Virus
BACKGROUND AND AIMS: Lamivudine (LAM) is still widely used for anti-HBV therapy in China. The study aimed to clarify whether a newly-found rtM204Q mutation from patients was associated with the drug resistance. METHODS: HBV complete reverse-transcriptase region was screened by direct sequencing and...
Autores principales: | Liu, Yan, Xu, Zhihui, Wang, Yan, Li, Xiaodong, Liu, Liming, Chen, Li, Xin, Shaojie, Xu, Dongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933355/ https://www.ncbi.nlm.nih.gov/pubmed/24586482 http://dx.doi.org/10.1371/journal.pone.0089015 |
Ejemplares similares
-
Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B
por: WANG, YANG, et al.
Publicado: (2016) -
Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice
por: Liu, Yan, et al.
Publicado: (2019) -
Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations
por: Choe, Won Hyeok, et al.
Publicado: (2019) -
Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi
por: Lai, Ming-Wei, et al.
Publicado: (2020) -
Association of Interferon-gamma Induced Protein 10 Promoter Polymorphisms with the Disease Progression of Hepatitis B Virus Infection in Chinese Han Population
por: Xu, Zhihui, et al.
Publicado: (2013)